SCHEDULE 13G/A
0001104659-24-010271
0001502725
XXXXXXXX
LIVE
2
Common Stock, par value $0.001 per share
12/19/2024
0001766140
UNICYCIVE THERAPEUTICS, INC.
90466Y103
4300 EL CAMINO REAL, SUITE 210,
LOS ALTOS
CA
94022
Rule 13d-1(c)
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
MA
0.00
3009021.00
0.00
3009021.00
3009021.00
N
2.76
PN
UNICYCIVE THERAPEUTICS, INC.
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS, CA, 94022
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP ("Nantahala")
130 Main St. 2nd Floor, New Canaan, CT 06840
Nantahala is a Massachusetts limited partnership.
Y
As of December 19, 2024, Nantahala may be deemed to be the beneficial owner of 3,009,021 Shares. The 3,009,021 Shares includes 479,364 Shares which may be acquired by the Reporting Persons within sixty days through the exercise of warrants.
As of December 19, 2024, each of the Reporting Persons may be deemed to be the beneficial owner of 2.76% of the total number of Shares outstanding, based on 108,420,957 shares outstanding received from the issuer on December 19, 2024.
0
3,009,021
0
3,009,021
N
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
/s/ Taki Vasilakis
12/20/2024
/s/ Wilmot B. Harkey
12/20/2024
/s/ Daniel Mack
12/20/2024